These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


212 related items for PubMed ID: 29195617

  • 1. PET/CT for Staging; Past, Present, and Future.
    El-Galaly TC, Gormsen LC, Hutchings M.
    Semin Nucl Med; 2018 Jan; 48(1):4-16. PubMed ID: 29195617
    [Abstract] [Full Text] [Related]

  • 2. Staging and response assessment in lymphomas: the new Lugano classification.
    Cheson BD.
    Chin Clin Oncol; 2015 Mar; 4(1):5. PubMed ID: 25841712
    [Abstract] [Full Text] [Related]

  • 3. FDG-PET/CT in the management of lymphomas: current status and future directions.
    El-Galaly TC, Villa D, Gormsen LC, Baech J, Lo A, Cheah CY.
    J Intern Med; 2018 Oct; 284(4):358-376. PubMed ID: 29989234
    [Abstract] [Full Text] [Related]

  • 4. PET/CT for Lymphoma Post-therapy Response Assessment in Other Lymphomas, Response Assessment for Autologous Stem Cell Transplant, and Lymphoma Follow-up.
    Karls S, Shah H, Jacene H.
    Semin Nucl Med; 2018 Jan; 48(1):37-49. PubMed ID: 29195616
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 18F-FDG PET/CT in the clinical management of patients with lymphoma.
    Tamayo P, Martín A, Díaz L, Cabrero M, García R, García-Talavera P, Caballero D.
    Rev Esp Med Nucl Imagen Mol; 2017 Jan; 36(5):312-321. PubMed ID: 28483374
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Positron emission tomography/computed tomography in the management of Hodgkin and B-cell non-Hodgkin lymphoma: An update.
    Juweid ME, Mueller M, Alhouri A, A-Risheq MZ, Mottaghy FM.
    Cancer; 2021 Oct 15; 127(20):3727-3741. PubMed ID: 34286864
    [Abstract] [Full Text] [Related]

  • 9. The role of 18F-FDG PET/CT in staging and restaging primary bone lymphoma.
    Liu Y.
    Nucl Med Commun; 2017 Apr 15; 38(4):319-324. PubMed ID: 28225435
    [Abstract] [Full Text] [Related]

  • 10. A comparison of clinical staging using the Lugano versus Ann Arbor classifications in Japanese patients with Hodgkin lymphoma.
    Makita S, Maruyama D, Maeshima AM, Taniguchi H, Yuda S, Toyoda K, Yamauchi N, Fukuhara S, Munakata W, Kobayashi Y, Kurihara H, Izutsu K, Tobinai K.
    Asia Pac J Clin Oncol; 2020 Jun 15; 16(3):108-114. PubMed ID: 31802636
    [Abstract] [Full Text] [Related]

  • 11. Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma.
    McCarten KM, Nadel HR, Shulkin BL, Cho SY.
    Pediatr Radiol; 2019 Oct 15; 49(11):1545-1564. PubMed ID: 31620854
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients.
    Mayerhoefer ME, Karanikas G, Kletter K, Prosch H, Kiesewetter B, Skrabs C, Porpaczy E, Weber M, Pinker-Domenig K, Berzaczy D, Hoffmann M, Sillaber C, Jaeger U, Müllauer L, Simonitsch-Klupp I, Dolak W, Gaiger A, Ubl P, Lukas J, Raderer M.
    Clin Cancer Res; 2014 Jun 01; 20(11):2984-93. PubMed ID: 24696320
    [Abstract] [Full Text] [Related]

  • 13. [Staging and Treatment Response Evaluation in Malignant Lymphomas - Czech Lymphoma Study Group Recommendations According to Criteria Revised in 2014 (Lugano Classification)].
    Sýkorová A, Pytlík R, Móciková H, Belada D, Benešová K, Papajík T, Janíková A, Šálek D, Procházka V, Vokurka S, Campr V, Klener P, Kubáčková K, Trněný M.
    Klin Onkol; 2016 Jun 01; 29(4):295-302. PubMed ID: 27534788
    [Abstract] [Full Text] [Related]

  • 14. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
    Teagle AR, Barton H, Charles-Edwards E, Dizdarevic S, Chevassut T.
    Acta Radiol; 2017 Dec 01; 58(12):1476-1484. PubMed ID: 28382828
    [Abstract] [Full Text] [Related]

  • 15. Role of bone marrow biopsy in staging of patients with classical Hodgkin's lymphoma undergoing positron emission tomography/computed tomography.
    Puccini B, Nassi L, Minoia C, Volpetti S, Ciancia R, Riccomagno PC, Di Rocco A, Mulè A, Toldo C, Sassone MC, Guariglia R, Filì C, Finolezzi E, Falorio S, Zanon S, Furlan A, Doa G, Zaja F, Fondazione Italiana Linfomi Postgraduate Master course.
    Ann Hematol; 2017 Jul 01; 96(7):1147-1153. PubMed ID: 28451805
    [Abstract] [Full Text] [Related]

  • 16. [Malignant lymphoma].
    Okamoto R.
    Gan To Kagaku Ryoho; 2009 Dec 01; 36(13):2532-6. PubMed ID: 20009452
    [Abstract] [Full Text] [Related]

  • 17. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
    Chavdarova LI, Tzonevska AD, Piperkova EN.
    Hell J Nucl Med; 2013 Dec 01; 16(3):223-9. PubMed ID: 24137584
    [Abstract] [Full Text] [Related]

  • 18. Can full-dose contrast-enhanced CT be omitted from an FDG-PET/CT staging examination in newly diagnosed FDG-avid lymphoma?
    van Hamersvelt HP, Kwee TC, Fijnheer R, Beek FJ, de Klerk JM, Nievelstein RA.
    J Comput Assist Tomogr; 2014 Dec 01; 38(4):620-5. PubMed ID: 24681861
    [Abstract] [Full Text] [Related]

  • 19. 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas.
    Specht L.
    Semin Radiat Oncol; 2007 Jul 01; 17(3):190-7. PubMed ID: 17591566
    [Abstract] [Full Text] [Related]

  • 20. Prognostic Importance of Bone Marrow Uptake on Baseline 18F-FDG Positron Emission Tomography in Diffuse Large B Cell Lymphoma.
    Soydal C, Koksoy EB, Yasar A, Turgal E, Erdogan BD, Akbulut H, Kucuk NO.
    Cancer Biother Radiopharm; 2016 Dec 01; 31(10):361-365. PubMed ID: 27996313
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.